IL5 and eosinophilic esophagitis: Bhardwaj et al.13 showed that topical beclomethasone dipropionate therapy results in a greatly decreases in eosinophilia number and IL-33 downstream cytokine (e.g., IL-3, IL-5, IL-13) levels in inflammatory esophageal tissues in a small cohort EoE patients, although the significance was not enough for them to report a significant improvement in clinical symptoms.